Kimelman & Baird LLC Sells 1,421 Shares of Teleflex Incorporated (NYSE:TFX)

Kimelman & Baird LLC reduced its stake in Teleflex Incorporated (NYSE:TFX) by 1.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 99,527 shares of the medical technology company’s stock after selling 1,421 shares during the period. Teleflex accounts for 2.0% of Kimelman & Baird LLC’s holdings, making the stock its 21st biggest holding. Kimelman & Baird LLC owned about 0.21% of Teleflex worth $24,615,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also modified their holdings of TFX. CWM LLC grew its stake in Teleflex by 22.9% in the second quarter. CWM LLC now owns 1,317 shares of the medical technology company’s stock worth $277,000 after purchasing an additional 245 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Teleflex by 99.3% during the 2nd quarter. SG Americas Securities LLC now owns 13,791 shares of the medical technology company’s stock worth $2,901,000 after buying an additional 6,871 shares in the last quarter. Czech National Bank grew its position in shares of Teleflex by 8.6% during the 2nd quarter. Czech National Bank now owns 8,975 shares of the medical technology company’s stock worth $1,888,000 after buying an additional 708 shares in the last quarter. Sequoia Financial Advisors LLC increased its stake in shares of Teleflex by 3.9% during the second quarter. Sequoia Financial Advisors LLC now owns 6,484 shares of the medical technology company’s stock valued at $1,364,000 after buying an additional 246 shares during the period. Finally, Hengehold Capital Management LLC bought a new stake in shares of Teleflex in the second quarter valued at about $216,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TFX has been the topic of several recent research reports. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Friday, November 1st. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Truist Financial restated a “hold” rating and set a $227.00 target price (down previously from $255.00) on shares of Teleflex in a report on Monday, November 4th. Finally, Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $259.00.

Teleflex Price Performance

Shares of TFX opened at $184.65 on Friday. The company has a 50 day moving average of $214.17 and a two-hundred day moving average of $221.42. The company has a market cap of $8.58 billion, a price-to-earnings ratio of 36.71, a price-to-earnings-growth ratio of 1.92 and a beta of 1.16. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $184.23 and a twelve month high of $257.85.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter last year, the firm earned $3.64 EPS. The business’s quarterly revenue was up 2.4% on a year-over-year basis. As a group, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.74%. The ex-dividend date is Friday, November 15th. Teleflex’s payout ratio is currently 27.04%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.